Literature DB >> 2199234

The blood-brain interface.

M W Bradbury1, S L Lightman.   

Abstract

The properties of the blood-brain barrier are those of the capillary endothelium in brain. This endothelium contrasts with that elsewhere in being sealed with tight junctions, having a high electrical resistance and low permeability to polar solutes. It is exceptional in having a paucity of pits and vesicles, a specialised enzyme content and a high density of mitochondria. Functionally, a range of transport mechanisms allow rapid movement of certain specific metabolic substrates. Ion pumps are concerned with secretion of brain interstitial fluid and regulation of its ionic concentration. The retinal capillaries are largely identical to those of the brain, but entry of solutes into retina is also determined by the properties of the pigment epithelium, functionally separating the retina from the highly vascular choroid. A clear difference lies in the greater resistance of cerebral microvessels to diabetic damage. The mechanism of this difference is unclear, but may relate to a better control of the brain interstitial fluid at a lower glucose concentration than is possible in the retinal interstitial fluid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199234     DOI: 10.1038/eye.1990.36

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  13 in total

Review 1.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

2.  [Immunotherapies for drug addictions].

Authors:  Ivan Montoya
Journal:  Adicciones       Date:  2008       Impact factor: 2.979

3.  The unfolded protein response to endoplasmic reticulum stress in cultured astrocytes and rat brain during experimental diabetes.

Authors:  Katrine R Lind; Kelly K Ball; Nancy F Cruz; Gerald A Dienel
Journal:  Neurochem Int       Date:  2013-02-11       Impact factor: 3.921

Review 4.  From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy.

Authors:  Joseph F Arboleda-Velasquez; Cammi N Valdez; Christina K Marko; Patricia A D'Amore
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

5.  Distribution of a putative endothelial barrier antigen in the ocular and orbital tissues of the rat.

Authors:  J G Lawrenson; M N Ghabriel; A R Reid; T N Gajree; G Allt
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

Review 6.  Developing a vaccine against multiple psychoactive targets: a case study of heroin.

Authors:  G Neilm Stowe; Joel E Schlosburg; Leandro F Vendruscolo; Scott Edwards; Kaushik K Misra; Gery Schulteis; Joseph S Zakhari; George F Koob; Kim D Janda
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

Review 7.  The Protective Effects of Neurotrophins and MicroRNA in Diabetic Retinopathy, Nephropathy and Heart Failure via Regulating Endothelial Function.

Authors:  Sergey Shityakov; Michiaki Nagai; Süleyman Ergün; Barbara M Braunger; Carola Y Förster
Journal:  Biomolecules       Date:  2022-08-12

8.  Glutamate permeability at the blood-brain barrier in insulinopenic and insulin-resistant rats.

Authors:  Richard A Hawkins; Ashwini Mokashi; Mary R Dejoseph; Juan R Viña; John D Fernstrom
Journal:  Metabolism       Date:  2009-09-29       Impact factor: 8.694

9.  Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice.

Authors:  R D Zhang; J E Price; T Fujimaki; C D Bucana; I J Fidler
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

Review 10.  In vitro techniques for the assessment of neurotoxicity.

Authors:  G J Harry; M Billingsley; A Bruinink; I L Campbell; W Classen; D C Dorman; C Galli; D Ray; R A Smith; H A Tilson
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.